Birmingham, West Midlands -- (SBWIRE) -- 12/13/2013 -- Value Penny Stocks issues special report on Merrimack Pharmaceuticals Inc (NASDAQ:MACK), E TRADE Financial Corporation (NASDAQ:ETFC), Prospect Capital Corporation (NASDAQ:PSEC), Northwest Biotherapeutics, Inc (NASDAQ:NWBO).
Merrimack Pharmaceuticals Inc (NASDAQ:MACK) opened its last trade at the price of $4.05. Its closing price was $4.54 after gaining 12.10% for the day. The company traded with the total volume of 2.75 million shares, while its average trading volume remained 2.80 million shares. Merrimack Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and preparing to commercialize medicines paired with companion diagnostics for the treatment of cancer in the United States.
For How Long MACK will Fight for Profitability? Read This Trend Analysis report
E TRADE Financial Corporation (NASDAQ:ETFC) percentage change plunged -0.38% to close at $18.40 with the total traded volume of 2.64 million shares, along with average volume of 2.61 million shares. The 52 week range of the stock remained $8.19 - $18.75, while its day lowest price was $18.27. The share price hit the day highest price of $18.55. E*TRADE Financial Corporation, a financial services company, provides online brokerage and related products and services primarily to individual retail investors under the E*TRADE Financial brand in the United States.
Has ETFC Found The Bottom And Ready To Gain Momentum? Find Out Here
Prospect Capital Corporation (NASDAQ:PSEC) traded on volume of 2.63 million shares in the last session against average volume of 2.92 million shares. The company started its trading session with the price of $11.12 and closed at $11.07 by scoring -0.45%. Prospect Capital Corporation is a business development company. It specializes in middle market, mature, mezzanine finance, later stage, emerging growth, buyouts, recapitalizations, turnaround, growth capital, development, cash flow term loans, and bridge transactions.
Why Should Investors Buy PSEC After the Recent Fall? Just Go Here and Find Out
Northwest Biotherapeutics, Inc (NASDAQ:NWBO) started its last trading session with the price of $3.74 and closed at $3.47 by scoring -12.15%. The stock traded with total volume of 2.60 million shares, while the average trading volume remained 1.55 million shares. The beta value of this stock stands at 1.61. Day range for the stock was $3.30 - $3.74. Northwest Biotherapeutics, Inc., a development stage biotechnology company, engages in discovering, developing, and commercializing immunotherapy products to treat cancers in the United States. Its DCVax uses activated dendritic cells to mobilize a patient’s own immune system to attack their cancer.
Will NWBO Get Buyers Even After The Recent Rally? Find Out Here
About Value Penny Stocks
Value Penny Stocks was made by Two Active traders, Steve and Wilson, whom have made a platform for traders in order to provide traders the #1 Penny Stock Newsletter which actually gives value to your money and makes your portfolio full of profits. We concentrate on small cap stocks that trade on NYSE, NASD, AMEX, OTCBB, and OTC exchanges. These are usually stocks that will trade under $5 a share and offer the utmost potential profit on your short or long term investment. We also devote ourselves to understanding the overall market situations and use this knowledge in order to gain a better perception during our stock picking decisions.
We at ValuePennyStocks.com are engaged in the business of marketing and advertising companies. All content on our website is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a solicitation of the purchase or sale of any securities.
Please Read Our Full Disclaimer at: http://www.valuepennystocks.com/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)